4//SEC Filing
ORAGENICS INC 4
Accession 0000899243-17-003783
$OGENCIK 0001174940operating
Filed
Feb 12, 7:00 PM ET
Accepted
Feb 13, 4:08 PM ET
Size
14.5 KB
Accession
0000899243-17-003783
Insider Transaction Report
Form 4
ORAGENICS INCOGEN.BC
KOSKI FAMILY LP
10% Owner
Transactions
- Award
Common Stock
2017-02-09+40,000→ 1,047,878 total
Holdings
- 12,864,822
Common Stock
- 1,572,523
Common Stock
- 28,000(indirect: By Koski Management, Inc.)
Common Stock
- 530,851(indirect: By Trust)
Common Stock
- 919,666
Common Stock
Footnotes (8)
- [F1]Shares owned directly by Koski Family Limited Partnership ("KFLP"). Shares owned indirectly by the KFLP general partners: Koski Management, Inc. (solely owned by Beverly Koski), Christine L. Koski, Robert C. Koski and Thomas L. Koski, each of whom is a general partner of the partnership or the controlling person of a corporate general partner of the partnership.
- [F2]Each reporting person disclaims beneficial ownership of all indirectly owned securities in excess of such reporting person's pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner for purposes of Section 16 or any other purpose.
- [F3]Shares owned directly by Christine L. Koski.
- [F4]Shares owned directly by Robert C. Koski, a director of the Company.
- [F5]Shares owned directly by Thomas L. Koski.
- [F6]Shares owned indirectly by Beverly Koski (through Koski Management, Inc.).
- [F7]Shares owned by trusts for Mr. Robert Koski's children of which Mr. Robert C. Koski serves as trustee. Such trusts are as follows: the Robert Clayton Koski Trust for the benefit of Anthony James Hunter (107,600 shares); the Robert Clayton Koski Trust for the benefit of Hunter Buchanan Koski (107,600 shares); the Robert Clayton Koski Trust for the benefit of Clayton Ward Bennett (100,000 shares); the Robert Clayton Koski Trust for the benefit of Robert Edward Koski (107,600 shares); and the Robert Clayton Koski Trust for the benefit of Elyse Margaux Koski (108,051 shares). Mr. Koski disclaims beneficial ownership of the shares held by the trusts except to the extent of any pecuniary interest.
- [F8]Represents an award of restricted stock in connection with service to the Company as director pursuant to the 2012 Equity Incentive Plan that vest equally over each of the four calendar quarters during 2017.
Documents
Issuer
ORAGENICS INC
CIK 0001174940
Entity typeoperating
IncorporatedFL
Related Parties
1- filerCIK 0001174940
Filing Metadata
- Form type
- 4
- Filed
- Feb 12, 7:00 PM ET
- Accepted
- Feb 13, 4:08 PM ET
- Size
- 14.5 KB